YKA-12473-05043
2 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 432 / OH
- Registered
- 2020-12-25
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-24
Dose 1 — Pfizer-BioNTech
-
2020-12-25
Registered in v-safe
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2021-01-02
- 2021-01-07
-
2021-01-14
Dose 2 — Pfizer-BioNTech
-
2021-02-04
Survey response — 21 day, dose 2MedDRA: Abortion spontaneous, Fatigue, Headache, Myalgia, Pregnancy, Pyrexia — Feeling: Poor · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-04-15
- 2021-07-15
- 2022-01-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-24 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech |
Free text
Release 3
Symptoms: Low grade fever, myalgias, headache, fatigue day after 2nd vaccination. Pregnant after taking 1st vaccination and had a miscarriage the week of 2nd vaccination.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release